Chemomab Therapeutics Ltd. Income Tax Expense Continuing Operations
Chemomab Therapeutics Ltd. (CMMB) reported Income Tax Expense Continuing Operations of $621.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2019-04-24
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2018-12-31 | $621.00K 20-F · filed 2019-04-24 |
| 2017-12-31 | $323.00K 20-F · filed 2019-04-24 |
| 2016-12-31 | $137.00K 20-F · filed 2019-04-24 |